Quarterly Holdings Report
for
Fidelity® Small Cap Growth K6 Fund
April 30, 2022
SCPK6-NPRT3-0622
1.9884009.104
Common Stocks - 94.9% | |||
Shares | Value ($) | ||
COMMUNICATION SERVICES - 4.7% | |||
Diversified Telecommunication Services - 0.2% | |||
IDT Corp. Class B (a) | 68,759 | 1,820,738 | |
Interactive Media & Services - 1.9% | |||
Bumble, Inc. (a) | 261,620 | 6,276,264 | |
CarGurus, Inc. Class A (a) | 207,994 | 6,797,244 | |
ZipRecruiter, Inc. (a) | 406,505 | 9,150,428 | |
22,223,936 | |||
Media - 1.8% | |||
Nexstar Broadcasting Group, Inc. Class A | 43,161 | 6,837,566 | |
TechTarget, Inc. (a) | 210,779 | 14,187,534 | |
21,025,100 | |||
Wireless Telecommunication Services - 0.8% | |||
Gogo, Inc. (a) | 489,519 | 9,012,045 | |
TOTAL COMMUNICATION SERVICES | 54,081,819 | ||
CONSUMER DISCRETIONARY - 11.0% | |||
Auto Components - 0.4% | |||
Gentherm, Inc. (a) | 77,097 | 5,197,880 | |
Diversified Consumer Services - 0.3% | |||
Duolingo, Inc. (a)(b) | 20,449 | 1,768,225 | |
Rover Group, Inc. Class A (a) | 222,250 | 1,406,843 | |
3,175,068 | |||
Hotels, Restaurants & Leisure - 2.6% | |||
Churchill Downs, Inc. | 41,334 | 8,388,322 | |
Dutch Bros, Inc. (b) | 96,598 | 4,614,486 | |
Everi Holdings, Inc. (a) | 166,099 | 2,883,479 | |
Lindblad Expeditions Holdings (a) | 756,868 | 11,587,649 | |
Planet Fitness, Inc. (a) | 29,060 | 2,325,672 | |
29,799,608 | |||
Household Durables - 1.1% | |||
GoPro, Inc. Class A (a) | 377,432 | 3,366,693 | |
Helen of Troy Ltd. (a) | 9,904 | 2,124,507 | |
Lovesac (a) | 160,192 | 7,022,817 | |
12,514,017 | |||
Internet & Direct Marketing Retail - 0.6% | |||
BARK, Inc. (a)(b) | 435,969 | 1,347,144 | |
BARK, Inc. (c) | 267,300 | 825,957 | |
BARK, Inc. warrants 8/29/25 (a) | 130,921 | 58,914 | |
Porch Group, Inc. Class A (a)(b) | 679,324 | 2,513,499 | |
thredUP, Inc. (a)(b) | 248,338 | 1,636,547 | |
6,382,061 | |||
Specialty Retail - 4.2% | |||
American Eagle Outfitters, Inc. (b) | 497,183 | 7,512,435 | |
Dick's Sporting Goods, Inc. | 46,901 | 4,522,194 | |
Fanatics, Inc. Class A (c)(d) | 163,048 | 11,061,176 | |
Five Below, Inc. (a) | 34,729 | 5,455,926 | |
Floor & Decor Holdings, Inc. Class A (a) | 73,447 | 5,855,195 | |
Lithia Motors, Inc. Class A (sub. vtg.) | 27,269 | 7,720,672 | |
Williams-Sonoma, Inc. (b) | 39,803 | 5,193,495 | |
47,321,093 | |||
Textiles, Apparel & Luxury Goods - 1.8% | |||
Algolia, Inc. (c)(d) | 43,269 | 1,265,404 | |
Crocs, Inc. (a) | 184,942 | 12,285,697 | |
Kontoor Brands, Inc. | 184,699 | 7,338,091 | |
20,889,192 | |||
TOTAL CONSUMER DISCRETIONARY | 125,278,919 | ||
CONSUMER STAPLES - 3.8% | |||
Food & Staples Retailing - 3.5% | |||
BJ's Wholesale Club Holdings, Inc. (a) | 217,569 | 14,000,565 | |
Grocery Outlet Holding Corp. (a)(b) | 129,702 | 4,367,066 | |
Performance Food Group Co. (a) | 236,917 | 11,668,162 | |
The Real Good Food Co. LLC (d) | 45,833 | 0 | |
U.S. Foods Holding Corp. (a) | 260,956 | 9,817,165 | |
39,852,958 | |||
Food Products - 0.0% | |||
The Real Good Food Co. LLC Class B unit | 45,833 | 324,883 | |
Personal Products - 0.3% | |||
The Beauty Health Co. (a)(b) | 214,511 | 2,810,094 | |
TOTAL CONSUMER STAPLES | 42,987,935 | ||
ENERGY - 5.2% | |||
Energy Equipment & Services - 0.6% | |||
TechnipFMC PLC (a) | 963,015 | 6,664,064 | |
Oil, Gas & Consumable Fuels - 4.6% | |||
Antero Resources Corp. (a) | 434,672 | 15,300,454 | |
Civitas Resources, Inc. | 46,600 | 2,731,692 | |
Denbury, Inc. (a) | 57,200 | 3,659,656 | |
Enviva, Inc. | 105,857 | 8,927,979 | |
Genesis Energy LP | 658,526 | 7,230,615 | |
HF Sinclair Corp. (a) | 78,300 | 2,976,966 | |
Northern Oil & Gas, Inc. | 102,435 | 2,558,826 | |
PDC Energy, Inc. | 32,236 | 2,248,139 | |
Range Resources Corp. (a) | 250,175 | 7,490,240 | |
53,124,567 | |||
TOTAL ENERGY | 59,788,631 | ||
FINANCIALS - 5.3% | |||
Banks - 1.6% | |||
East West Bancorp, Inc. | 24,046 | 1,714,480 | |
Glacier Bancorp, Inc. | 49,992 | 2,287,634 | |
Independent Bank Group, Inc. | 25,918 | 1,757,240 | |
Metropolitan Bank Holding Corp. (a) | 13,050 | 1,162,103 | |
PacWest Bancorp | 82,771 | 2,722,338 | |
Pinnacle Financial Partners, Inc. | 34,898 | 2,706,340 | |
Signature Bank | 9,502 | 2,301,860 | |
Silvergate Capital Corp. (a) | 17,942 | 2,098,496 | |
Starling Bank Ltd. Series D (a)(c)(d) | 431,700 | 1,280,019 | |
18,030,510 | |||
Capital Markets - 1.7% | |||
Impax Asset Management Group PLC | 139,046 | 1,503,743 | |
Lazard Ltd. Class A | 74,422 | 2,438,809 | |
LPL Financial | 27,210 | 5,111,943 | |
Morningstar, Inc. | 8,478 | 2,146,884 | |
Perella Weinberg Partners (c) | 457,262 | 3,525,490 | |
StepStone Group, Inc. Class A | 127,005 | 3,253,868 | |
StoneX Group, Inc. (a) | 19,911 | 1,349,568 | |
19,330,305 | |||
Insurance - 1.6% | |||
American Financial Group, Inc. | 42,824 | 5,930,268 | |
Assurant, Inc. | 37,080 | 6,744,110 | |
BRP Group, Inc. (a) | 209,436 | 4,842,160 | |
17,516,538 | |||
Thrifts & Mortgage Finance - 0.4% | |||
Walker & Dunlop, Inc. | 41,353 | 4,952,435 | |
TOTAL FINANCIALS | 59,829,788 | ||
HEALTH CARE - 22.6% | |||
Biotechnology - 7.5% | |||
4D Molecular Therapeutics, Inc. (a)(b) | 68,480 | 815,597 | |
ADC Therapeutics SA (a) | 56,818 | 668,748 | |
Agios Pharmaceuticals, Inc. (a) | 22,463 | 493,512 | |
ALX Oncology Holdings, Inc. (a)(b) | 165,691 | 2,117,531 | |
Argenx SE ADR (a) | 19,382 | 5,568,836 | |
Ascendis Pharma A/S sponsored ADR (a) | 53,351 | 4,869,346 | |
Avid Bioservices, Inc. (a) | 80,532 | 1,083,961 | |
Bicycle Therapeutics PLC ADR (a) | 36,333 | 853,099 | |
Blueprint Medicines Corp. (a) | 96,700 | 5,642,445 | |
Celldex Therapeutics, Inc. (a) | 105,637 | 3,227,210 | |
Century Therapeutics, Inc. | 92,055 | 1,106,501 | |
Cyteir Therapeutics, Inc. | 120,462 | 271,040 | |
Cytokinetics, Inc. (a) | 164,892 | 6,574,244 | |
Erasca, Inc. | 229,619 | 1,671,626 | |
Exelixis, Inc. (a) | 149,488 | 3,339,562 | |
Forma Therapeutics Holdings, Inc. (a) | 17,264 | 130,516 | |
Global Blood Therapeutics, Inc. (a) | 134,229 | 4,120,830 | |
Graphite Bio, Inc. | 98,826 | 397,281 | |
Halozyme Therapeutics, Inc. (a)(b) | 74,931 | 2,989,747 | |
Imago BioSciences, Inc. | 106,624 | 1,743,302 | |
Immunocore Holdings PLC ADR (a) | 67,421 | 2,198,599 | |
Instil Bio, Inc. (a) | 338,123 | 2,390,530 | |
Janux Therapeutics, Inc. | 88,614 | 871,962 | |
Keros Therapeutics, Inc. (a) | 56,575 | 2,999,041 | |
Monte Rosa Therapeutics, Inc. (b) | 120,166 | 1,309,809 | |
Morphic Holding, Inc. (a) | 84,604 | 2,564,347 | |
Nuvalent, Inc. (e) | 124,141 | 1,277,411 | |
Prelude Therapeutics, Inc. (a)(b) | 154,900 | 710,991 | |
Protagonist Therapeutics, Inc. (a) | 74,863 | 680,505 | |
PTC Therapeutics, Inc. (a) | 100,378 | 3,546,355 | |
Relay Therapeutics, Inc. (a)(b) | 193,380 | 4,608,245 | |
Repare Therapeutics, Inc. (a)(b) | 127,997 | 1,407,967 | |
Revolution Medicines, Inc. (a) | 4,583 | 91,523 | |
Tango Therapeutics, Inc. (a) | 113,500 | 835,360 | |
Tenaya Therapeutics, Inc. (a) | 152,945 | 1,410,153 | |
TG Therapeutics, Inc. (a) | 217,598 | 1,510,130 | |
Tyra Biosciences, Inc. (b) | 141,598 | 1,057,737 | |
United Therapeutics Corp. (a) | 16,310 | 2,896,004 | |
Vericel Corp. (a)(b) | 60,981 | 1,737,959 | |
Verve Therapeutics, Inc. | 108,763 | 1,622,744 | |
Xenon Pharmaceuticals, Inc. (a) | 77,513 | 2,191,293 | |
85,603,599 | |||
Health Care Equipment & Supplies - 5.1% | |||
Envista Holdings Corp. (a) | 179,234 | 7,101,251 | |
Figs, Inc. Class A (a)(b) | 986,900 | 15,454,854 | |
Globus Medical, Inc. (a) | 55,001 | 3,642,166 | |
Insulet Corp. (a) | 56,324 | 13,460,873 | |
Integer Holdings Corp. (a) | 67,173 | 5,049,394 | |
Lantheus Holdings, Inc. (a) | 45,537 | 3,024,112 | |
LivaNova PLC (a) | 55,904 | 4,285,601 | |
Minerva Surgical, Inc. (b) | 172,517 | 417,491 | |
NeuroPace, Inc. (a)(b) | 248,346 | 1,996,702 | |
TransMedics Group, Inc. (a) | 128,134 | 2,685,689 | |
ViewRay, Inc. (a) | 460,626 | 1,229,871 | |
58,348,004 | |||
Health Care Providers & Services - 6.1% | |||
Acadia Healthcare Co., Inc. (a) | 147,875 | 10,037,755 | |
agilon health, Inc. (a) | 368,307 | 6,544,815 | |
Molina Healthcare, Inc. (a) | 32,478 | 10,180,229 | |
Option Care Health, Inc. (a) | 294,635 | 8,803,694 | |
Owens & Minor, Inc. | 151,402 | 5,373,257 | |
R1 RCM, Inc. (a) | 368,346 | 8,295,152 | |
Surgery Partners, Inc. (a) | 189,990 | 9,719,888 | |
Tenet Healthcare Corp. (a) | 90,943 | 6,594,277 | |
The Ensign Group, Inc. | 27,200 | 2,184,976 | |
The Joint Corp. (a) | 33,826 | 1,032,370 | |
68,766,413 | |||
Health Care Technology - 2.0% | |||
Doximity, Inc. | 58,008 | 2,312,779 | |
Evolent Health, Inc. (a) | 229,253 | 6,309,043 | |
Health Catalyst, Inc. (a) | 50,282 | 836,692 | |
Inspire Medical Systems, Inc. (a) | 43,335 | 8,916,610 | |
OptimizeRx Corp. (a)(b) | 37,922 | 1,065,987 | |
Phreesia, Inc. (a) | 72,659 | 1,662,438 | |
Schrodinger, Inc. (a) | 46,698 | 1,154,375 | |
22,257,924 | |||
Life Sciences Tools & Services - 1.0% | |||
Absci Corp. (b) | 191,936 | 1,134,342 | |
Olink Holding AB ADR (a)(b) | 170,867 | 2,474,154 | |
Syneos Health, Inc. (a) | 79,823 | 5,834,263 | |
Veterinary Emergency Group LLC Class A (c)(d)(f) | 38,574 | 2,020,267 | |
11,463,026 | |||
Pharmaceuticals - 0.9% | |||
Arvinas Holding Co. LLC (a) | 60,353 | 3,317,604 | |
DICE Therapeutics, Inc. | 87,400 | 1,775,968 | |
Edgewise Therapeutics, Inc. (a) | 172,144 | 1,373,709 | |
Ikena Oncology, Inc. (a) | 142,155 | 551,561 | |
NGM Biopharmaceuticals, Inc. (a) | 76,723 | 957,503 | |
Pharvaris BV (a)(b) | 123,453 | 2,098,701 | |
10,075,046 | |||
TOTAL HEALTH CARE | 256,514,012 | ||
INDUSTRIALS - 17.9% | |||
Aerospace & Defense - 2.0% | |||
AeroVironment, Inc. (a) | 33,791 | 2,714,093 | |
BWX Technologies, Inc. | 83,950 | 4,358,684 | |
Curtiss-Wright Corp. | 60,900 | 8,703,219 | |
Dassault Aviation SA | 15,900 | 2,668,101 | |
Maxar Technologies, Inc. | 47,900 | 1,542,859 | |
Triumph Group, Inc. (a) | 145,000 | 3,268,300 | |
23,255,256 | |||
Air Freight & Logistics - 0.5% | |||
Air Transport Services Group, Inc. (a) | 120,912 | 3,784,546 | |
Hub Group, Inc. Class A (a) | 37,132 | 2,493,785 | |
6,278,331 | |||
Building Products - 1.5% | |||
Builders FirstSource, Inc. (a) | 108,382 | 6,673,080 | |
The AZEK Co., Inc. (a) | 197,709 | 4,199,339 | |
UFP Industries, Inc. | 76,443 | 5,914,395 | |
16,786,814 | |||
Commercial Services & Supplies - 0.7% | |||
Driven Brands Holdings, Inc. (a) | 162,823 | 4,541,133 | |
HNI Corp. | 81,516 | 2,905,230 | |
7,446,363 | |||
Construction & Engineering - 2.1% | |||
NV5 Global, Inc. (a) | 22,151 | 2,653,690 | |
Valmont Industries, Inc. | 18,300 | 4,553,223 | |
Willscot Mobile Mini Holdings (a) | 472,079 | 16,569,973 | |
23,776,886 | |||
Electrical Equipment - 1.7% | |||
Acuity Brands, Inc. | 24,001 | 4,139,692 | |
Array Technologies, Inc. (a) | 411,800 | 2,689,054 | |
nVent Electric PLC | 171,867 | 5,805,667 | |
Regal Rexnord Corp. | 51,975 | 6,613,299 | |
19,247,712 | |||
Machinery - 1.7% | |||
Chart Industries, Inc. (a) | 14,900 | 2,515,418 | |
Crane Co. | 92,661 | 8,916,768 | |
ITT, Inc. | 47,151 | 3,310,943 | |
Mueller Industries, Inc. | 93,170 | 5,045,156 | |
19,788,285 | |||
Marine - 0.4% | |||
Kirby Corp. (a) | 65,243 | 4,253,844 | |
Professional Services - 5.2% | |||
Alight, Inc. Class A (a) | 481,753 | 4,138,258 | |
ASGN, Inc. (a) | 110,827 | 12,573,323 | |
CACI International, Inc. Class A (a) | 62,416 | 16,558,965 | |
First Advantage Corp. | 72,941 | 1,266,256 | |
FTI Consulting, Inc. (a) | 26,979 | 4,254,858 | |
KBR, Inc. | 354,077 | 17,431,211 | |
Korn Ferry | 37,592 | 2,309,652 | |
TriNet Group, Inc. (a) | 8,436 | 748,273 | |
59,280,796 | |||
Trading Companies & Distributors - 2.1% | |||
Applied Industrial Technologies, Inc. | 80,466 | 8,423,986 | |
Beacon Roofing Supply, Inc. (a) | 108,645 | 6,478,501 | |
Custom Truck One Source, Inc. Class A (a)(b) | 504,944 | 3,317,482 | |
Univar Solutions, Inc. (a) | 175,510 | 5,110,851 | |
23,330,820 | |||
TOTAL INDUSTRIALS | 203,445,107 | ||
INFORMATION TECHNOLOGY - 17.1% | |||
Communications Equipment - 0.5% | |||
Lumentum Holdings, Inc. (a) | 74,559 | 6,054,936 | |
Electronic Equipment & Components - 2.2% | |||
Fabrinet (a) | 107,514 | 10,556,800 | |
Insight Enterprises, Inc. (a) | 38,024 | 3,778,445 | |
TD SYNNEX Corp. | 78,545 | 7,861,569 | |
Vontier Corp. | 118,200 | 3,028,284 | |
25,225,098 | |||
IT Services - 2.3% | |||
Concentrix Corp. | 52,301 | 8,236,361 | |
Digitalocean Holdings, Inc. (a) | 63,850 | 2,517,606 | |
Dlocal Ltd. (b) | 21,004 | 476,161 | |
ExlService Holdings, Inc. (a) | 6,749 | 918,876 | |
Flywire Corp. (a) | 44,548 | 1,359,159 | |
Genpact Ltd. | 89,298 | 3,596,030 | |
Perficient, Inc. (a) | 26,030 | 2,587,642 | |
Verra Mobility Corp. (a) | 406,359 | 5,701,217 | |
25,393,052 | |||
Semiconductors & Semiconductor Equipment - 3.0% | |||
AEHR Test Systems (a) | 132,205 | 1,015,334 | |
Cirrus Logic, Inc. (a) | 80,771 | 6,122,442 | |
eMemory Technology, Inc. | 57,000 | 2,396,877 | |
MACOM Technology Solutions Holdings, Inc. (a) | 105,298 | 5,364,933 | |
Nova Ltd. (a) | 66,262 | 6,534,096 | |
SiTime Corp. (a) | 71,750 | 12,094,898 | |
33,528,580 | |||
Software - 7.8% | |||
Alkami Technology, Inc. (a) | 182,184 | 2,386,610 | |
Braze, Inc. | 41,254 | 1,657,998 | |
CCC Intelligent Solutions Holdings, Inc. (c) | 10,832 | 99,979 | |
Confluent, Inc. (b) | 60,500 | 1,890,020 | |
CyberArk Software Ltd. (a)(b) | 34,419 | 5,408,602 | |
DoubleVerify Holdings, Inc. (a) | 242,489 | 5,274,136 | |
Dynatrace, Inc. (a) | 205,564 | 7,885,435 | |
Elastic NV (a) | 95,124 | 7,242,741 | |
Five9, Inc. (a) | 16,866 | 1,856,947 | |
GitLab, Inc. | 31,242 | 1,497,429 | |
KnowBe4, Inc. (a) | 396,682 | 9,441,032 | |
Rapid7, Inc. (a)(b) | 79,842 | 7,626,508 | |
Sprout Social, Inc. (a) | 144,873 | 8,877,817 | |
TECSYS, Inc. | 149,573 | 3,038,847 | |
Telos Corp. (a) | 203,310 | 1,583,785 | |
Tenable Holdings, Inc. (a) | 330,804 | 18,270,305 | |
WalkMe Ltd. (b) | 142,906 | 2,267,918 | |
Yext, Inc. (a) | 440,543 | 2,550,744 | |
88,856,853 | |||
Technology Hardware, Storage & Peripherals - 1.3% | |||
Avid Technology, Inc. (a) | 472,635 | 14,987,256 | |
TOTAL INFORMATION TECHNOLOGY | 194,045,775 | ||
MATERIALS - 5.0% | |||
Chemicals - 3.5% | |||
Axalta Coating Systems Ltd. (a) | 118,984 | 3,018,624 | |
Cabot Corp. | 111,005 | 7,309,679 | |
Element Solutions, Inc. | 324,002 | 6,680,921 | |
Huntsman Corp. | 205,869 | 6,972,783 | |
The Chemours Co. LLC | 122,124 | 4,038,641 | |
Trinseo PLC | 121,947 | 5,786,385 | |
Valvoline, Inc. | 181,159 | 5,476,437 | |
39,283,470 | |||
Construction Materials - 0.3% | |||
Eagle Materials, Inc. | 24,730 | 3,049,704 | |
Containers & Packaging - 0.2% | |||
Ardagh Metal Packaging SA (c) | 364,084 | 2,595,919 | |
Metals & Mining - 1.0% | |||
Commercial Metals Co. | 58,200 | 2,386,200 | |
Iluka Resources Ltd. | 751,231 | 5,884,318 | |
Lynas Rare Earths Ltd. (a) | 532,149 | 3,339,324 | |
11,609,842 | |||
TOTAL MATERIALS | 56,538,935 | ||
REAL ESTATE - 1.3% | |||
Equity Real Estate Investment Trusts (REITs) - 0.6% | |||
Rexford Industrial Realty, Inc. | 43,225 | 3,373,279 | |
Terreno Realty Corp. | 41,431 | 3,014,105 | |
6,387,384 | |||
Real Estate Management & Development - 0.7% | |||
Compass, Inc. (a) | 305,041 | 1,656,373 | |
Jones Lang LaSalle, Inc. (a) | 31,188 | 6,821,751 | |
8,478,124 | |||
TOTAL REAL ESTATE | 14,865,508 | ||
UTILITIES - 1.0% | |||
Independent Power and Renewable Electricity Producers - 1.0% | |||
NextEra Energy Partners LP | 42,903 | 2,859,914 | |
Sunnova Energy International, Inc. (a)(b) | 149,855 | 2,587,996 | |
Vistra Corp. | 224,100 | 5,606,982 | |
11,054,892 | |||
TOTAL COMMON STOCKS (Cost $1,071,188,137) | 1,078,431,321 | ||
Convertible Preferred Stocks - 2.6% | |||
Shares | Value ($) | ||
COMMUNICATION SERVICES - 0.2% | |||
Interactive Media & Services - 0.2% | |||
Reddit, Inc. Series F (c)(d) | 46,800 | 1,855,620 | |
CONSUMER DISCRETIONARY - 0.0% | |||
Textiles, Apparel & Luxury Goods - 0.0% | |||
Algolia SAS Series D (c)(d) | 9,900 | 289,526 | |
HEALTH CARE - 0.4% | |||
Biotechnology - 0.4% | |||
Bright Peak Therapeutics AG Series B (c)(d) | 199,331 | 458,461 | |
Caris Life Sciences, Inc. Series D (c)(d) | 144,435 | 961,937 | |
LifeMine Therapeutics, Inc. Series C (c)(d) | 402,743 | 820,222 | |
Sonoma Biotherapeutics, Inc.: | |||
Series B (c)(d) | 438,013 | 613,218 | |
Series B1 (c)(d) | 233,603 | 327,044 | |
T-Knife Therapeutics, Inc. Series B (c)(d) | 201,583 | 641,034 | |
Treeline Biosciences Series A (c)(d) | 21,246 | 100,706 | |
3,922,622 | |||
Health Care Providers & Services - 0.0% | |||
Boundless Bio, Inc. Series B (c)(d) | 682,407 | 511,805 | |
Health Care Technology - 0.0% | |||
Wugen, Inc. Series B (c)(d) | 59,982 | 259,722 | |
TOTAL HEALTH CARE | 4,694,149 | ||
INDUSTRIALS - 0.9% | |||
Construction & Engineering - 0.6% | |||
Beta Technologies, Inc.: | |||
Series A (c)(d) | 62,752 | 6,474,124 | |
Series B, 6.00% (c)(d) | 11,821 | 1,219,573 | |
7,693,697 | |||
Road & Rail - 0.3% | |||
Convoy, Inc. Series D (a)(c)(d) | 192,936 | 3,183,039 | |
TOTAL INDUSTRIALS | 10,876,736 | ||
INFORMATION TECHNOLOGY - 1.1% | |||
Communications Equipment - 0.4% | |||
Astranis Space Technologies Corp. Series C (a)(c)(d) | 125,912 | 4,001,483 | |
IT Services - 0.4% | |||
Yanka Industries, Inc.: | |||
Series E (a)(c)(d) | 191,029 | 3,986,775 | |
Series F (c)(d) | 28,989 | 605,000 | |
4,591,775 | |||
Software - 0.3% | |||
Mountain Digital, Inc. Series D (c)(d) | 140,383 | 3,223,938 | |
Skyryse, Inc. Series B (c)(d) | 12,000 | 296,160 | |
3,520,098 | |||
TOTAL INFORMATION TECHNOLOGY | 12,113,356 | ||
TOTAL CONVERTIBLE PREFERRED STOCKS (Cost $28,165,522) | 29,829,387 | ||
Investment Companies - 2.0% | |||
Shares | Value ($) | ||
iShares Russell 2000 Growth Index ETF (b) (Cost $23,655,625) | 101,800 | 22,863,265 | |
Money Market Funds - 6.3% | |||
Shares | Value ($) | ||
Fidelity Cash Central Fund 0.32% (g) | 18,368,441 | 18,372,115 | |
Fidelity Securities Lending Cash Central Fund 0.32% (g)(h) | 53,000,367 | 53,005,667 | |
TOTAL MONEY MARKET FUNDS (Cost $71,377,782) | 71,377,782 | ||
TOTAL INVESTMENT IN SECURITIES - 105.8% (Cost $1,194,387,066) | 1,202,501,755 |
NET OTHER ASSETS (LIABILITIES) - (5.8)% | (66,315,042) |
NET ASSETS - 100.0% | 1,136,186,713 |
Security Type Abbreviations
ETF | - | EXCHANGE-TRADED FUND |
Legend
(a) | Non-income producing |
(b) | Security or a portion of the security is on loan at period end. |
(c) | Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $52,503,598 or 4.6% of net assets. |
(d) | Level 3 security |
(e) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $1,277,411 or 0.1% of net assets. |
(f) | Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes. |
(g) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
(h) | Investment made with cash collateral received from securities on loan. |
Additional information on each restricted holding is as follows: | ||
Security | Acquisition Date | Acquisition Cost ($) |
Algolia SAS Series D | 7/23/21 | 289,526 |
Algolia, Inc. | 10/27/21 | 1,265,404 |
Ardagh Metal Packaging SA | 2/22/21 | 3,640,840 |
Astranis Space Technologies Corp. Series C | 3/19/21 | 2,760,108 |
BARK, Inc. | 12/17/20 | 2,673,000 |
Beta Technologies, Inc. Series A | 4/09/21 | 4,597,839 |
Beta Technologies, Inc. Series B, 6.00% | 4/04/22 | 1,219,573 |
Boundless Bio, Inc. Series B | 4/23/21 | 921,249 |
Bright Peak Therapeutics AG Series B | 5/14/21 | 778,587 |
Caris Life Sciences, Inc. Series D | 5/11/21 | 1,169,924 |
CCC Intelligent Solutions Holdings, Inc. | 2/02/21 | 108,320 |
Convoy, Inc. Series D | 10/30/19 | 2,612,353 |
Fanatics, Inc. Class A | 8/13/20 - 3/22/21 | 2,891,600 |
LifeMine Therapeutics, Inc. Series C | 2/15/22 | 820,222 |
Mountain Digital, Inc. Series D | 11/05/21 | 3,223,938 |
Perella Weinberg Partners | 12/29/20 | 4,572,620 |
Reddit, Inc. Series F | 8/11/21 | 2,891,978 |
Skyryse, Inc. Series B | 10/21/21 | 296,160 |
Sonoma Biotherapeutics, Inc. Series B | 7/26/21 | 865,645 |
Sonoma Biotherapeutics, Inc. Series B1 | 7/26/21 | 692,516 |
Starling Bank Ltd. Series D | 6/18/21 - 4/05/22 | 824,189 |
T-Knife Therapeutics, Inc. Series B | 6/30/21 | 1,162,892 |
Treeline Biosciences Series A | 7/30/21 | 166,303 |
Veterinary Emergency Group LLC Class A | 9/16/21 - 3/17/22 | 1,900,945 |
Wugen, Inc. Series B | 7/09/21 | 465,154 |
Yanka Industries, Inc. Series E | 5/15/20 | 2,307,478 |
Yanka Industries, Inc. Series F | 4/08/21 | 924,077 |
Affiliated Central Funds
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
Affiliate | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | %ownership, end of period |
Fidelity Cash Central Fund 0.32% | 4,152,847 | 445,759,948 | 431,540,680 | 11,740 | - | - | 18,372,115 | 0.0% |
Fidelity Securities Lending Cash Central Fund 0.32% | 107,112,980 | 310,727,605 | 364,834,918 | 542,574 | - | - | 53,005,667 | 0.1% |
Total | 111,265,827 | 756,487,553 | 796,375,598 | 554,314 | - | - | 71,377,782 |
Amounts in the income column in the above table include any capital gain distributions from underlying funds.
Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee.
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
Level 1 - Unadjusted quoted prices in active markets for identical investments
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
Valuation techniques used to value investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
Securities, including private placements or other restricted securities, for which observable inputs are not available are valued using alternate valuation approaches, including the market approach, the income approach and cost approach, and are categorized as Level 3 in the hierarchy. The market approach considers factors including the price of recent investments in the same or a similar security or financial metrics of comparable securities. The income approach considers factors including expected future cash flows, security specific risks and corresponding discount rates. The cost approach considers factors including the value of the security's underlying assets and liabilities.
Exchange-Traded Funds (ETFs) and Exchange-Traded Notes (ETNs) are valued at their last sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day but the exchange reports a closing bid level, ETFs and ETNs are valued at the closing bid and would be categorized as Level 1 in the hierarchy. In the event there was no closing bid, ETFs and ETNs may be valued by another method that the Board believes reflects fair value in accordance with the Board's fair value pricing policies and may be categorized as Level 2 in the hierarchy.
Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.